Safety, tolerability, pharmacokinetics and effect on serum uric acid of the myeloperoxidase inhibitor AZD4831 in a randomized, placebo-controlled, phase I study in healthy volunteers.

Name: Safety, tolerability, pharmacokinetics and effect on serum uric acid of the myeloperoxidase inhibitor AZD4831 in a randomized, placebo-controlled, phase I study in healthy volunteers.
Author: Gan, Li-Ming

Safety, tolerability, pharmacokinetics and effect on serum uric acid of the myeloperoxidase inhibitor AZD4831 in a randomized, placebo-controlled, phase I study in healthy volunteers. — المؤلف: Gan, Li-Ming — British journal of clinical pharmacology 20200420

المؤلف: Gan, Li-Ming
النشر: British journal of clinical pharmacology 20200420
الوصف: 762-770 p.
الموضوعات: Administration, Oral؛ Adult؛ Area Under Curve؛ Cardiovascular Diseases؛ Drug Administration Schedule؛ Enzyme Inhibitors؛ Half-Life؛ Healthy Volunteers